Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients

Detalhes bibliográficos
Autor(a) principal: Enacán,Rosa E.
Data de Publicação: 2019
Outros Autores: Miñana,Mariana Nuñez, Fernandez,Luis, Valle,Maria Gabriela, Salerno,Mercedes, Fraga,Claudia I., Santos-Simarro,Fernando, Prieto,Laura, Lapunzina,Pablo, Specola,Norma, Chiesa,Ana Elena
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Journal of Inborn Errors of Metabolism and Screening
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942019000100309
Resumo: Abstract Phenylketonuria (PKU, OMIM 261600) is predominantly caused by mutations in the PAH gene. One hundred and three Argentine PKU patients were studied by Sanger sequencing; 101 were completely characterized (90.3% were compound heterozygotes). Fifty-four different pathogenic variants were identified. Mutations were distributed all along the PAH gene but concentrated in exon 7 (26%), 12 (12%), 11 (10%), and 6 (10%). 77% were missense, and 77% affected the enzyme catalytic domain, nine mutations accounted for 57% of 179 studied alleles: p.Arg261Gln (Allele frequency(AF):10.6%), c.1066-11G>A (AF:9,5%), p.Arg408Trp (AF:8,3%), p.Tyr414Cys (AF:5,5%), p.Ala403Val, p.Val388Met, and p.Arg158Gln (AF: 5% each), p.Leu48Ser, and p.Ile65Thr (AF:4% each). The predicted phenotype was assigned by Guldberg´s arbitrary value (AV) and compared with the clinical phenotype based in tolerance to Phe intake. 29.1% (n:30) were hyperphenylalaninemias, 18.5% (n:19) mild-PKU, 27.2% (n:28) moderate-PKU and 25.2 % (n:26) classical-PKU. Genotype/phenotype correlation was statistically significant (p<0.001) Overall concordance was 62,5%: 93.3% in hyperphenylalaninemia, 64.7% in mild-PKU and 65.4% in classical patients. The moderate-PKU showed a weak concordance (17%) with milder AV prediction than clinical assessment. 74% of discordant moderate patients harbored p.Arg261Gln, and p.Val388Met. Our cohort is highly heterogeneous, with predominant Mediterranean influence (mainly Spanish), but with differences with other Latin-American countries.
id IGPT-1_e2b6d41d174eb7cb98201a6f9fa9b92b
oai_identifier_str oai:scielo:S2326-45942019000100309
network_acronym_str IGPT-1
network_name_str Journal of Inborn Errors of Metabolism and Screening
repository_id_str
spelling Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine PatientsPkugenotypephenylalanine hydroxylaseAbstract Phenylketonuria (PKU, OMIM 261600) is predominantly caused by mutations in the PAH gene. One hundred and three Argentine PKU patients were studied by Sanger sequencing; 101 were completely characterized (90.3% were compound heterozygotes). Fifty-four different pathogenic variants were identified. Mutations were distributed all along the PAH gene but concentrated in exon 7 (26%), 12 (12%), 11 (10%), and 6 (10%). 77% were missense, and 77% affected the enzyme catalytic domain, nine mutations accounted for 57% of 179 studied alleles: p.Arg261Gln (Allele frequency(AF):10.6%), c.1066-11G>A (AF:9,5%), p.Arg408Trp (AF:8,3%), p.Tyr414Cys (AF:5,5%), p.Ala403Val, p.Val388Met, and p.Arg158Gln (AF: 5% each), p.Leu48Ser, and p.Ile65Thr (AF:4% each). The predicted phenotype was assigned by Guldberg´s arbitrary value (AV) and compared with the clinical phenotype based in tolerance to Phe intake. 29.1% (n:30) were hyperphenylalaninemias, 18.5% (n:19) mild-PKU, 27.2% (n:28) moderate-PKU and 25.2 % (n:26) classical-PKU. Genotype/phenotype correlation was statistically significant (p<0.001) Overall concordance was 62,5%: 93.3% in hyperphenylalaninemia, 64.7% in mild-PKU and 65.4% in classical patients. The moderate-PKU showed a weak concordance (17%) with milder AV prediction than clinical assessment. 74% of discordant moderate patients harbored p.Arg261Gln, and p.Val388Met. Our cohort is highly heterogeneous, with predominant Mediterranean influence (mainly Spanish), but with differences with other Latin-American countries.Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)2019-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942019000100309Journal of Inborn Errors of Metabolism and Screening v.7 2019reponame:Journal of Inborn Errors of Metabolism and Screeninginstname:Instituto Genética para Todos (IGPT)instacron:IGPT10.1590/2326-4594-jiems-2019-0012info:eu-repo/semantics/openAccessEnacán,Rosa E.Miñana,Mariana NuñezFernandez,LuisValle,Maria GabrielaSalerno,MercedesFraga,Claudia I.Santos-Simarro,FernandoPrieto,LauraLapunzina,PabloSpecola,NormaChiesa,Ana Elenaeng2019-12-12T00:00:00Zoai:scielo:S2326-45942019000100309Revistahttp://jiems-journal.org/ONGhttps://old.scielo.br/oai/scielo-oai.phpjiems@jiems-journal.org||rgiugliani@hcpa.edu.br2326-45942326-4594opendoar:2019-12-12T00:00Journal of Inborn Errors of Metabolism and Screening - Instituto Genética para Todos (IGPT)false
dc.title.none.fl_str_mv Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients
title Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients
spellingShingle Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients
Enacán,Rosa E.
Pku
genotype
phenylalanine hydroxylase
title_short Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients
title_full Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients
title_fullStr Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients
title_full_unstemmed Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients
title_sort Phenylalanine Hydroxylase (PAH) Genotyping in PKU Argentine Patients
author Enacán,Rosa E.
author_facet Enacán,Rosa E.
Miñana,Mariana Nuñez
Fernandez,Luis
Valle,Maria Gabriela
Salerno,Mercedes
Fraga,Claudia I.
Santos-Simarro,Fernando
Prieto,Laura
Lapunzina,Pablo
Specola,Norma
Chiesa,Ana Elena
author_role author
author2 Miñana,Mariana Nuñez
Fernandez,Luis
Valle,Maria Gabriela
Salerno,Mercedes
Fraga,Claudia I.
Santos-Simarro,Fernando
Prieto,Laura
Lapunzina,Pablo
Specola,Norma
Chiesa,Ana Elena
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Enacán,Rosa E.
Miñana,Mariana Nuñez
Fernandez,Luis
Valle,Maria Gabriela
Salerno,Mercedes
Fraga,Claudia I.
Santos-Simarro,Fernando
Prieto,Laura
Lapunzina,Pablo
Specola,Norma
Chiesa,Ana Elena
dc.subject.por.fl_str_mv Pku
genotype
phenylalanine hydroxylase
topic Pku
genotype
phenylalanine hydroxylase
description Abstract Phenylketonuria (PKU, OMIM 261600) is predominantly caused by mutations in the PAH gene. One hundred and three Argentine PKU patients were studied by Sanger sequencing; 101 were completely characterized (90.3% were compound heterozygotes). Fifty-four different pathogenic variants were identified. Mutations were distributed all along the PAH gene but concentrated in exon 7 (26%), 12 (12%), 11 (10%), and 6 (10%). 77% were missense, and 77% affected the enzyme catalytic domain, nine mutations accounted for 57% of 179 studied alleles: p.Arg261Gln (Allele frequency(AF):10.6%), c.1066-11G>A (AF:9,5%), p.Arg408Trp (AF:8,3%), p.Tyr414Cys (AF:5,5%), p.Ala403Val, p.Val388Met, and p.Arg158Gln (AF: 5% each), p.Leu48Ser, and p.Ile65Thr (AF:4% each). The predicted phenotype was assigned by Guldberg´s arbitrary value (AV) and compared with the clinical phenotype based in tolerance to Phe intake. 29.1% (n:30) were hyperphenylalaninemias, 18.5% (n:19) mild-PKU, 27.2% (n:28) moderate-PKU and 25.2 % (n:26) classical-PKU. Genotype/phenotype correlation was statistically significant (p<0.001) Overall concordance was 62,5%: 93.3% in hyperphenylalaninemia, 64.7% in mild-PKU and 65.4% in classical patients. The moderate-PKU showed a weak concordance (17%) with milder AV prediction than clinical assessment. 74% of discordant moderate patients harbored p.Arg261Gln, and p.Val388Met. Our cohort is highly heterogeneous, with predominant Mediterranean influence (mainly Spanish), but with differences with other Latin-American countries.
publishDate 2019
dc.date.none.fl_str_mv 2019-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942019000100309
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942019000100309
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/2326-4594-jiems-2019-0012
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)
publisher.none.fl_str_mv Latin American Society Inborn Errors and Neonatal Screening (SLEIMPN); Instituto Genética para Todos (IGPT)
dc.source.none.fl_str_mv Journal of Inborn Errors of Metabolism and Screening v.7 2019
reponame:Journal of Inborn Errors of Metabolism and Screening
instname:Instituto Genética para Todos (IGPT)
instacron:IGPT
instname_str Instituto Genética para Todos (IGPT)
instacron_str IGPT
institution IGPT
reponame_str Journal of Inborn Errors of Metabolism and Screening
collection Journal of Inborn Errors of Metabolism and Screening
repository.name.fl_str_mv Journal of Inborn Errors of Metabolism and Screening - Instituto Genética para Todos (IGPT)
repository.mail.fl_str_mv jiems@jiems-journal.org||rgiugliani@hcpa.edu.br
_version_ 1754732520217247744